img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
April 1, 2021
img
img
Protagenic Therapeutics, Inc.
(Nasdaq: PTIX)

$13,197,000

Uplisting
and Underwritten Public Offering
Sole Bookrunner

March 1, 2021
img
img
American Acquisition Opportunity Inc.
(Nasdaq: AMAOU)

$105,060,020

SPAC IPO
Sole Bookrunnner

March 1, 2021
img
img
Hoth Therapeutics Inc.
(Nasdaq: HOTH)

$15,000,000

Private Placement
Financial Advisor

March 1, 2021
img
The Glimpse Group
()

Private Placement
Placement Agent

March 1, 2021
img
img
Cootek (Cayman) Inc.
(NYSE: CTK)

$20,000,000

Private Placement
Exclusive Placement Agent

March 1, 2021
img
img
Healthcare Triangle Inc.
()

$4,000,000

Private Placement
Placement Agent

March 1, 2021
img
img
Grom Social Enterprises Inc.
(OTCPK: GRMM)

Private Placement
Placement Agent

March 1, 2021
img
img
IMAC Holdings, Inc.
(Nasdaq: IMAC)

$19,550,000

Underwritten Public Offering
Sole Bookrunner

March 1, 2021
img
img
Agriforce Growing Systems, Ltd.
()

Private Placement
Placement Agent

March 1, 2021
img
img
Infinity Energy Resources, Inc.
(OTCPK: IFNY)


Advisory
Financial Advisor

March 1, 2021
img
img
B. Riley Financial, Inc.
(Nasdaq: RILY)

$159,493,250

Senior Notes
Co-Manager

March 1, 2021
img
img
Wizard Brands, Inc.
(OTCPK: WIZD)

Private Placement
Placement Agent

1 … 25 26 27 28 29 … 34
Insights
  • April 9, 2025

    D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in connection with its $4.0 Million Initial Public Offering

    Read More icon Read More icon
  • March 27, 2025

    D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

    Read More icon Read More icon
  • March 26, 2025

    D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

    Read More icon Read More icon
  • March 4, 2025

    D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

    Read More icon Read More icon
img
View All

Together, let's build meaningful value.